Connect with us

Hi, what are you looking for?

Jewish Business News

Leadership & A-List

Cambrex names Shlomo Yanai chairman

shlomo-yanai-izhar[6

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.

Former Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) CEO Shlomo Yanai has been appointed chairman of US drug development company Cambrex Corporation (NYSE: CBM). He succeeds John Miller, who stepped down on April 24, after six years. He served on Cambrex’s board of directors since 1998.

“I would like to thank John for his exceptional leadership of the Cambrex board, ” said Cambrex president and CEO Steven Klosk. “As we look forward to Mr. Yanai’s leadership as our new chairman, we are fortunate to have the benefit of an outstanding life science leader who has previously led Teva Pharmaceutical, one of the world’s largest pharmaceutical companies, during a period of tremendous growth. Shlomo’s in-depth knowledge of our industry will be a great asset as we look to accelerate our strategic growth initiatives.”

Yanai joined Cambrex as vice chairman in November 2012, after serving as Teva’s president and CEO from 2007 to mid-2012, “during which time Teva increased revenues from $8.4 billion to approximately $20 billion, ” states Cambrex.

In a filing with the US Securities and Exchange Commission (SEC), Cambrex said that Yanai will be paid a salary of $245, 000 a year, and will receive $50, 000 in shares, which will be vested for six months, and options exercisable for shares worth $30, 000.

Published by Globes [online], Israel business news – www.globes-online.com 

Newsletter



Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Entertainment

The Movie The Professional is what made Natalie Portman a Lolita.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.